InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Garland Greg C., Chief Executive Officer. Director active across 3 companies, notably AMGEN INC. Aggregated, 12 reports have been logged. The latest transaction was disclosed on 9 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€10m146,700 shares@ €69.81220.020% mcap83.5% of flow
Common Stock
SEC:0001534701-22-000122:0·
0855 shares0
Common Stock
SEC:0001127602-22-015175:0·
17,500 shares
Common Stock
SEC:0001534701-22-000090:0·
35,000 shares
Common Units
SEC:0000899243-22-010222:0·
028,074 shares0
Common Stock
SEC:0001534701-22-000073·
028,074 shares0
Common Stock
SEC:0001534701-22-000073:0·
€912,15411,780 shares@ €77.43240.0018% mcap90.3% of flow
Common Stock
SEC:0001534701-22-000057·
€912,15411,780 shares@ €77.43240.0018% mcap7.4% of flow
Common Stock
SEC:0001534701-22-000057:0·
€97,9021,569 shares@ €62.39740.0002% mcap9.7% of flow
Common Stock
SEC:0001534701-21-000181·
€97,9021,569 shares@ €62.39740.0002% mcap0.8% of flow
Common Stock
SEC:0001534701-21-000181:0·
0837 shares0
Common Stock
SEC:0001127602-21-017465·
0837 shares0
Common Stock
SEC:0001127602-21-017465:0·
12 of 12 declarations
About Garland Greg C.
Greg C. Garland is the Chairman and CEO of Amgen Inc. and Phillips 66. He leads the strategic operations of both companies, bringing his expertise in management and innovation.
